Zimmer Holdings Inc (ZMH)

ZMH on New York Consolidated

114.91USD
19 Dec 2014
Price Change (% chg)

$-0.03 (-0.03%)
Prev Close
$114.94
Open
$115.63
Day's High
$116.04
Day's Low
$114.05
Volume
1,271,670
Avg. Vol
1,038,533
52-wk High
$116.04
52-wk Low
$90.48

ZMH

Chart for ZMH

About

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, biologics, dental implants and related surgical products. The Company’s customers include orthopaedic surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare... (more)

Overall

Beta: 0.91
Market Cap (Mil.): $19,460.45
Shares Outstanding (Mil.): 169.35
Dividend: 0.22
Yield (%): 0.77

Financials

  ZMH Industry Sector
P/E (TTM): 24.74 34.98 38.47
EPS (TTM): 4.64 -- --
ROI: 9.32 10.78 18.25
ROE: 12.61 12.60 19.13
Search Stocks

U.S. appeals court cuts damages Zimmer must pay Stryker

- A U.S. federal appeals court has slashed the damages that Zimmer Holdings Inc will have to pay Stryker Corp for infringing its patents on a surgical cleaning wand.

19 Dec 2014

U.S. appeals court cuts damages Zimmer must pay Stryker

- A U.S. federal appeals court has slashed the damages that Zimmer Holdings Inc will have to pay Stryker Corp for infringing its patents on a surgical cleaning wand.

19 Dec 2014

U.S. appeals court cuts damages Zimmer must pay Stryker

Dec 19 - A U.S. federal appeals court has slashed the damages that Zimmer Holdings Inc will have to pay Stryker Corp for infringing its patents on a surgical cleaning wand.

19 Dec 2014

EU mergers and takeovers (Dec 4)

BRUSSELS, Dec 4 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

04 Dec 2014

EU mergers and takeovers (Nov 18)

BRUSSELS, Nov 18 - The following are mergers under review by the European Commission and a brief guide to the EU merger process:

18 Nov 2014

EU regulators extend Zimmer, Biomet deal deadline to March 11

BRUSSELS - European Union antitrust regulators will decide on U.S. medical device maker Zimmer's $13.4 billion bid for Biomet [LVBHAB.UL] by March 11, a three-week extension from the previous deadline, the European Commission said on Friday.

10 Oct 2014

EU regulators extend Zimmer, Biomet deal deadline to March 11

BRUSSELS, Oct 10 - European Union antitrust regulators will decide on U.S. medical device maker Zimmer's $13.4 billion bid for Biomet by March 11, a three-week extension from the previous deadline, the European Commission said on Friday.

10 Oct 2014

Deals of the day- Mergers and acquisitions

(Adds Zimmer, Medtronic, TIM Participações, Comcast, Chiquita, JPMorgan Chase & Co, Fortress and Ilva)

03 Oct 2014

EU regulators open extensive probe into Zimmer, Biomet deal

BRUSSELS - European Union antitrust regulators opened on Friday an extensive investigation into U.S. medical device maker Zimmer's $13.4 billion bid for Biomet [LVBHAB.UL], increasing the pressure on Zimmer to offer concessions to allay their concerns.

03 Oct 2014

UPDATE 1-EU regulators open extensive probe into Zimmer, Biomet deal

* Zimmer may have to offer concessions in return for EU okay

03 Oct 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: GlobalData
$125.00
Provider: Wright Reports
$75.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks